iiinova — where your digital self keeps evolving

We're proud to partner with the Academy of Medical Sciences to launch a new fellowship programme focused on rare diseases. Supporting clinician scientists with the skills, networks and experience to translate research into patient impact. Learn more and apply: t.ly/12yhw

000

LifeArc @lifearc.bsky.social · 29/09/2026

What could the next generation of genetic medicines mean for people with rare diseases? Experts at our Translational Science Summit earlier this year explored the opportunities and challenges shaping the field. Catch up with the accessible summaries: bit.ly/3UY0Fr4

bit.ly

Using Gene Therapy to Treat Rare Diseases

Our summary of the opportunities that gene therapy could bring for patients, as discussed at the LifeArc Translational Science Summit 2026

010

LifeArc @lifearc.bsky.social · 25/09/2026

A good discussion is one thing, but turning conversation into action is another. Our workshops showed the value of a clear decision-making framework to propel actionable outputs. We're sharing 7 lessons from our childhood cancer workshops. Read them all: t.ly/oMPZi

000

Reposted by LifeArc

ESCMID @escmid.bsky.social · 23/09/2026

Bringing together all aspects of the #AMR research lifecycle is a key benefit of #GAMRIC2026. In the current session, we hear from the different perspectives throughout the lifecycle including IPC, clinical, innovators and trial-design. CARB-X LifeArc Global Antibiotic R&D Partnership (GARDP)

142

Reposted by LifeArc

ESCMID @escmid.bsky.social · 23/09/2026

Day 2 of #GAMRIC2026 starts off with discussions on addressing the gaps and unmet needs in #AMR particularly how to accelerate impact in paediatric AMR and in LMICs. Talks by Marcela Ramirez, Nina Putri, Tanu Singhal CARB-X LifeArc Global Antibiotic R&D Partnership (GARDP)

131

Reposted by LifeArc

ESCMID @escmid.bsky.social · 22/09/2026

Day 1 wrap-up of #GAMRIC2026 is now live on our LinkedIn (lnkd.in/p/e89DW9N3) CARB-X LifeArc Global Antibiotic R&D Partnership (GARDP)

132

LifeArc @lifearc.bsky.social · 17/09/2026

To improve treatment approaches, we need to first understand the unmet need. Engaging the community early can help define the challenge and uncover the barriers holding progress back. We're sharing 7 lessons from our childhood cancer workshops. Read them all: t.ly/oMPZi

000

LifeArc @lifearc.bsky.social · 16/09/2026

Why choose a career in cystic fibrosis research? 4 researchers from across the CF Lung Health Network share what motivates them and the difference they hope to make for people living with CF. #CysticFibrosis #ResearchCareer

022

LifeArc @lifearc.bsky.social · 11/09/2026

The Future For Rare Summit brought together over 100 people from across the UK, including those affected by rare conditions, support organisations, clinicians, researchers and policymakers, to agree the priorities for a new UK-wide rare disease policy.

000

LifeArc @lifearc.bsky.social · 09/09/2026

What should the future look like for people living with rare conditions? With Genetic Alliance UK and Newcastle University, we've brought together the rare disease community to help shape the next generation of UK rare disease policy at the #FutureForRare summit.

000

LifeArc @lifearc.bsky.social · 08/09/2026

"The next three years will be pivotal." In @healthcaretoday.bsky.social's latest interview, our CEO Sam Barrell discusses the changes needed to accelerate rare disease research in the UK and deliver greater patient impact. healthcaretoday.com/article/life...

healthcaretoday.com

LifeArc’s Sam Barrell: Real promise in rare diseases

The chief executive officer of LifeArc explains what we need to do to turn discovery science into patient benefit and why the UK has the potential to position itself as a market leader for rare diseas...

021

LifeArc @lifearc.bsky.social · 08/09/2026

Well-designed workshops can help communities move from shared concern to shared action. This Childhood Cancer Awareness Month, we're sharing 7 lessons from our Paediatric Therapeutic Development Workshop series. Read now: www.lifearc.org/2026/7-lessons-from…

001

LifeArc @lifearc.bsky.social · 02/09/2026

Only 8 bespoke childhood cancer medicines have been approved in the last 20 years. This #ChildhoodCancerAwarenessMonth, learn why a child-first approach to drug development is urgently needed. 🎥 Watch now: bit.ly/4x0hteg

000

LifeArc @lifearc.bsky.social · 01/09/2026

Are you searching for support, information or connections in the rare disease community? Raremap helps you find charities, patient organisations and more: raremap.co.uk/

031

LifeArc @lifearc.bsky.social · 25/08/2026

Osteosarcoma remains a major unmet need in young people. We’ve identified new targets to support the development of more targeted, less toxic treatments. 🔗Read more in British Journal of Cancer: www.nature.com/articles/s41416-026-…

000

LifeArc @lifearc.bsky.social · 24/08/2026

Kath Bainbridge reflects on five years of progress through England’s Rare Diseases Action Plans and what comes next to continue driving change for the rare disease community. Watch this #LATSS2026 session and 30+ more on our YouTube channel: t.ly/COXC_

000

LifeArc @lifearc.bsky.social · 20/08/2026

How do you build a great biotech company? Few people are better placed to answer that question than Christoph Lengauer, co-founder/CSO of Curie.Bio, and a man who has contributed to 11 FDA-approved medicines. Watch his session from our Translational Science Summit: t.ly/Kqqbx

010

LifeArc @lifearc.bsky.social · 18/08/2026

We need your help to build a resource that reflects the full scope of work happening across rare diseases in the UK. If your organisation isn't on Raremap yet, request to be added now: raremap.co.uk/join/

000

LifeArc @lifearc.bsky.social · 17/08/2026

Reasons to invest in rare disease research are not rare. Rare diseases are often described as too small, too complex or too expensive. But Alexion has proved that they can offer both the opportunity to change lives and generate financial returns. 🎥Watch the full video:

000

LifeArc @lifearc.bsky.social · 14/08/2026

Bio-Hermes-002 has now completed enrolment, with 28% of participants coming from traditionally understudied populations. We're proud to be part of the Bio-Hermes-002 study, which is testing whether a finger-prick blood test could help diagnose Alzheimer's disease.

000

LifeArc @lifearc.bsky.social · 12/08/2026

#GAMRIC2026 is fast approaching! Valeria Gigante (WHO) tells us why this conference is so important for tackling drug-resistant infections, together. Register now: gamric.org #Global Health #AMR

000

LifeArc @lifearc.bsky.social · 10/08/2026

What if patients with Hunter syndrome could become their own bone marrow donors? Professor Wynn shares how gene correction is transforming treatment, with dramatic results from clinical trials. Watch this #LATSS2026 session and 30+ more on our YouTube channel: t.ly/jLQmp

000

LifeArc @lifearc.bsky.social · 06/08/2026

#GAMRIC2026 is next month! If you haven't registered yet, get inspired by what our Chair of Global Health, Kelly Chibale, had to say about last year's edition. Register now: gamric.org #GlobalHealth #AMR

011

LifeArc @lifearc.bsky.social · 05/08/2026

Looking for collaboration, funding and support opportunities for your rare disease research? Explore Raremap to find the connections you need: raremap.co.uk/

000

LifeArc @lifearc.bsky.social · 03/08/2026

Why should investors pay more attention to rare diseases? During his panel, Chris Molloy shares why the sector offers both patient impact and commercial value. Watch the recording from #LATSS2026, plus 30+ other sessions, on our YouTube channel: youtu.be/ZbrD0yq0idg?...

000

LifeArc @lifearc.bsky.social · 31/07/2026

This week, @telegraph.co.uk explored how ASPIRE, a programme we support through our partnership with @reactgroup.bsky.social, is strengthening antimicrobial stewardship across Zambia and Kenya. Read now: www.telegraph.co.uk/global-healt...

telegraph.co.uk

010

LifeArc @lifearc.bsky.social · 31/07/2026

Imaging is one of the most powerful tools for drug discovery, allowing us to see biology in action. Here, Becca from our imaging team shows us how we quality-check neurons generated from our in-house induced pluripotent stem cell capability.

000

LifeArc @lifearc.bsky.social · 30/07/2026

Drug-resistant infections are a global challenge. GAMRIC brings together the people developing the solutions. Join the #AMR community in Lisbon this September for three days of discussion, collaboration and new ideas. Register today 👉 gamric.org

142

LifeArc @lifearc.bsky.social · 28/07/2026

In a letter published today in the @financialtimes.com, our CEO Sam Barrell welcomes increased investment in rare diseases while arguing that much more needs to be done to bring new treatments to patients. www.ft.com/content/d365...

ft.com

Letter: UK can lead way on rare disease treatments

From Sam Barrell, CEO of LifeArc, London WC1H, UK

011

LifeArc @lifearc.bsky.social · 28/07/2026

Is your organisation on Raremap yet? Join the living resource that makes the UK rare disease landscape easier to navigate. Visit Raremap now and request to be added: raremap.co.uk/join/

001

LifeArc @lifearc.bsky.social · 27/07/2026

A decade after her daughter Mila received the first medicine designed for a single individual, Julia Vitarello explains what’s needed to make individualised medicines accessible to all. Watch this #LATSS2026 session and 30+ more on our YouTube channel: bit.ly/3TkAuKb

000

LifeArc @lifearc.bsky.social · 24/07/2026

Drug-resistant infections pose a huge global health challenge. This week, we were in Zambia at the ReAct Africa Annual AMR Conference and to meet the ASPIRE programme team, working for better-informed antibiotic prescription decisions. Find out more: t.ly/LcRUQ

110

LifeArc @lifearc.bsky.social · 24/07/2026

We brought together clinicians, researchers and patient advocates to prioritise new treatment approaches for medulloblastoma. For high-risk disease, we focused on tumour ‘drivers’; for lower-risk subtypes, on opportunities for kinder, antibody-based treatments. 🔗https://t.ly/dE8h-

000

LifeArc @lifearc.bsky.social · 23/07/2026

It's brilliant to have so many organisations joining Raremap. If you work in rare diseases and are not part of the directory yet, apply to be added now.

011

LifeArc @lifearc.bsky.social · 21/07/2026

What would it take to make cancer non-lethal within our lifetime? Reed Jobs, Founder of Yosemite, explores how his venture capital firm is helping accelerate the next generation of cancer breakthroughs. Watch 30+ #LATSS2026 sessions on our YouTube channel: www.youtube.com/watch?v=aLRS...

youtube.com

(Opening Plenary) A new model for oncology innovation: how Yosemite funds what matters | LATSS 2026

YouTube video by LifeArc

000

LifeArc @lifearc.bsky.social · 17/07/2026

The UK has been at the forefront of many scientific and medical breakthroughs over the past century. So we're proud to be featured in Monarchy and Democracy: A History of Leadership, which showcases organisations that have contributed to leadership and progress in the UK.

000

LifeArc @lifearc.bsky.social · 16/07/2026

Rare disease affects millions of people worldwide, but making progress can be hindered by small numbers. That's where Our Future Health comes in. Read more about how this rich dataset is helping change the outlook for people with rare diseases: t.ly/TdkjX

010

LifeArc @lifearc.bsky.social · 15/07/2026

The rare disease landscape can be complex to navigate – that's why we've collaborated with @rdrukhub.bsky.social to launch Raremap. It's a searchable directory of rare disease organisations so you can find out who does what and how to connect. Visit Raremap now: t.ly/nY3Rz

000

LifeArc @lifearc.bsky.social · 14/07/2026

12 childhood cancers. 12 workshops. 24 months. We've just hosted the final Paediatric Therapeutic Development Workshop – a major milestone towards new treatment options for childhood cancers with the greatest unmet need. Read more: t.ly/SO81e

001

LifeArc @lifearc.bsky.social · 13/07/2026

"A hospital admission can be a major setback for someone with dementia. If we can spot problems earlier and help people stay safely at home, that has the potential to change lives, not just ease pressure on health services," says our CEO Sam Barrell in today's @express.co.uk

100

LifeArc @lifearc.bsky.social · 13/07/2026

We're pleased to announce that over 30 recordings from #LATSS2026 are now available. If you weren't able to attend, or would like to revisit any of the sessions, you can explore them at your leisure on our YouTube channel: t.ly/OygJ3

000

LifeArc @lifearc.bsky.social · 10/07/2026

Between 60–70% of medulloblastoma patients survive, but many face long-term side effects. For the highest-risk groups, survival is below 10%. Our workshop identified new treatment approaches to help address these urgent unmet needs for children. 🔗 Read more: t.ly/g5-qs

010

LifeArc @lifearc.bsky.social · 08/07/2026

The first edition of the Global AMR Innovators Conference left a lasting impression. #GAMRIC2026 is coming to Lisbon in September – find out more and register now: gamric.org/

000

LifeArc @lifearc.bsky.social · 07/07/2026

Our new partnership with University of Birmingham will see us developing a new targeted antibody for autoimmune diseases with our B-SMArT platform. An exciting step forward in finding safer, more targeted treatment options for patients.

000

LifeArc @lifearc.bsky.social · 06/07/2026

At the LifeArc Translational Science Summit, our CEO Sam Barrell reflected on the importance of bringing together the translational community and why the UK is so well-placed to advance treatments for people living with rare diseases. #LATSS2026

011

LifeArc @lifearc.bsky.social · 30/06/2026

AI has the power to transform brain health, but only if it works for everyone. Most AI models are built on Global North datasets, yet 71% of dementia cases will be in low and middle-resource settings by 2050. We explore why equity matters and more in our recent blog. Read now: t.ly/p1e3F

t.ly

The future of brain health: Early detection, equity and systematic change - LifeArc

The brain is the foundation of how we live, work, and connect and as societies age, the burden of brain-health conditions is rapidly rising. By 2050, more than 2.1 billion people will be over the age ...

000

Reposted by LifeArc

Cystic Fibrosis Trust @cysticfibrosis.org.uk · 27/06/2026

Today is #WorldMicrobiomeDay! We spoke to early career researchers Heritage and Lillie to find out more about the LUNG microbiome and why they’re studying it to improve treatments for CF lung infections. ➡️ ow.ly/nBox50ZhuyN #PrecisionCF LifeArc #cysticfibrosis #cftrust

162

LifeArc @lifearc.bsky.social · 29/06/2026

Some stories stay with you. In this video, Angela shares her family’s heartbreaking experience with childhood cancer. It’s a deeply moving reminder of the urgent need to advance research and development of new treatments: t.ly/qp45C

t.ly

"It's something no family should go through" | Why we work in childhood cancer

Enjoy the videos and music you love, upload original content, and share it all with friends, family, and the world on YouTube.

000